Onconetix, Inc. Stock Option, Exercise Price, Decrease
Onconetix, Inc. (ONCO) reported Stock Option, Exercise Price, Decrease of $3.14 per share for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-12-10.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:StockOptionExercisePriceDecrease · last filed 2025-06-02
- Onconetix, Inc. stock option, exercise price, decrease for the quarter ending 2024-03-31 was $3.16.
- Onconetix, Inc. stock option, exercise price, decrease for fiscal 2023 was $3.94.
| Period end | Stock Option, Exercise Price, Decrease | Stock Option, Exercise Price, Decrease as first filed | Stock Option, Exercise Price, Decrease 3 month | Stock Option, Exercise Price, Decrease 6 month | Stock Option, Exercise Price, Decrease 9 month | Stock Option, Exercise Price, Decrease 12 month |
|---|---|---|---|---|---|---|
| 2024-09-30 | $3.14 10-Q · filed 2024-12-10 | |||||
| 2024-06-30 | $3.15 10-Q · filed 2024-08-29 | |||||
| 2024-03-31 | $3.16 10-Q · filed 2024-05-20 | |||||
| 2023-12-31 | $3.94 10-K · filed 2024-04-11 | |||||
| 2023-07-31 | $43.60 10-K · filed 2025-06-02 | $1.09 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |